Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?

[1] Njei B(2016)Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis J Gastroenterol Hepatol. 31 1141-6

[2] McCarty TR(2015)Esophageal and esophagogastric junction cancers, version 1.2015 J Natl Compr Canc Netw. 13 194-227

[3] Birk JW(2008)The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg. 248 549-56

[4] Ajani JA(2010)Optimum lymphadenectomy for esophageal cancer Ann Surg. 251 46-50

[5] D’Amico TA(2007)Clinical impact of lymphadenectomy extent in resectable esophageal cancer J Gastrointest Surg. 11 1384-93

[6] Almhanna K(2014)Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival Ann Surg. 260 786-92

[7] Bentrem DJ(2015)Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial Ann Surg. 261 902-8

[8] Besh S(2008)The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg. 247 365-71

[9] Chao J(2010)The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma Ann Surg Oncol. 17 791-803

[10] Peyre CG(2011)Prognostic implications of lymphadenectomy in esophageal cancer after neo-adjuvant therapy: a single center experience J Gastrointest Surg. 15 1769-76

[1] Njei B(2016)Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis J Gastroenterol Hepatol. 31 1141-6

[2] McCarty TR(2015)Esophageal and esophagogastric junction cancers, version 1.2015 J Natl Compr Canc Netw. 13 194-227

[3] Birk JW(2008)The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg. 248 549-56

[4] Ajani JA(2010)Optimum lymphadenectomy for esophageal cancer Ann Surg. 251 46-50

[5] D’Amico TA(2007)Clinical impact of lymphadenectomy extent in resectable esophageal cancer J Gastrointest Surg. 11 1384-93

[6] Almhanna K(2014)Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival Ann Surg. 260 786-92

[7] Bentrem DJ(2015)Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial Ann Surg. 261 902-8

[8] Besh S(2008)The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg. 247 365-71

[9] Chao J(2010)The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma Ann Surg Oncol. 17 791-803

[10] Peyre CG(2011)Prognostic implications of lymphadenectomy in esophageal cancer after neo-adjuvant therapy: a single center experience J Gastrointest Surg. 15 1769-76